MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with E

Etoposide

Etoposide 50mg capsules

Incompatible

Stability notes for Etoposide 50mg capsules

Cytotoxic medicine. Not recommended due to handler risk.

Suppliers

Etoposide 50mg capsules (Alliance Healthcare (Distribution) Ltd)
Etoposide 50mg capsules (Neon Healthcare Ltd)

Etoposide 100mg capsules

Incompatible

Stability notes for Etoposide 100mg capsules

Cytotoxic medicine. Not recommended due to handler risk.

Suppliers

Etoposide 100mg capsules (Alliance Healthcare (Distribution) Ltd)
Etoposide 100mg capsules (Neon Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.